{"count": 10, "results": [{"_id": "40023279", "pmid": 40023279, "title": "Metformin as an Adjunct Treatment to Temozolomide for High-Grade Gliomas: A Systematic Review and Meta-Analysis.", "journal": "World Neurosurg", "authors": ["Thomaz de Assis EB", "Ferreira MY", "Sales de Oliveira J", "Mitre LP", "Correa da Silva EM", "Salim Coelho LL", "Moreno DA", "Polverini AD"], "date": "2025-02-27T00:00:00Z", "doi": "10.1016/j.wneu.2025.123842", "meta_date_publication": "2025 Feb 27", "meta_volume": "", "meta_issue": "", "meta_pages": "123842", "score": 50251.6, "text_hl": "METHODS: A systematic search on PubMed, Embase, and Cochrane Library databases was conducted for studies comparing @CHEMICAL_Temozolomide @CHEMICAL_MESH:D000077204 @@@TMZ@@@+@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ vs. @CHEMICAL_Temozolomide @CHEMICAL_MESH:D000077204 @@@TMZ@@@ alone for @<m>DISEASE_Lymphoma_Non_Hodgkin</m> @DISEASE_MESH:D008228 @@@HGG@@@. ", "citations": {"NLM": "Thomaz de Assis EB, Ferreira MY, Sales de Oliveira J, Mitre LP, Correa da Silva EM, Salim Coelho LL, Moreno DA, Polverini AD. Metformin as an Adjunct Treatment to Temozolomide for High-Grade Gliomas: A Systematic Review and Meta-Analysis. World Neurosurg. 2025 Feb 27;():123842. PMID: 40023279", "BibTeX": "@article{40023279, title={Metformin as an Adjunct Treatment to Temozolomide for High-Grade Gliomas: A Systematic Review and Meta-Analysis.}, author={Thomaz de Assis EB and Ferreira MY and Sales de Oliveira J and Mitre LP and Correa da Silva EM and Salim Coelho LL and Moreno DA and Polverini AD}, journal={World Neurosurg}, pages={123842}}"}}, {"_id": "36444502", "pmid": 36444502, "title": "Diabetes, metformin use and risk of non-Hodgkin's lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative.", "journal": "Int J Cancer", "authors": ["Wang Z", "Phillips LS", "Rohan TE", "Ho GYF", "Shadyab AH", "Bidulescu A", "Rudick CN", "Pan K", "Chen Z", "Luo J"], "date": "2023-04-15T00:00:00Z", "doi": "10.1002/ijc.34376", "meta_date_publication": "2023 Apr 15", "meta_volume": "152", "meta_issue": "8", "meta_pages": "1556-1569", "score": 50250.652, "text_hl": "Epidemiologic evidence is limited about associations between T2DM, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and the risk of @<m>DISEASE_Lymphoma_Non_Hodgkin</m> @DISEASE_MESH:D008228 @@@non-Hodgkin's lymphoma@@@ (@<m>DISEASE_Lymphoma_Non_Hodgkin</m> @DISEASE_MESH:D008228 @@@NHL@@@). ", "citations": {"NLM": "Wang Z, Phillips LS, Rohan TE, Ho GYF, Shadyab AH, Bidulescu A, Rudick CN, Pan K, Chen Z, Luo J. Diabetes, metformin use and risk of non-Hodgkin's lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative. Int J Cancer. 2023 Apr 15;152(8):1556-1569. PMID: 36444502", "BibTeX": "@article{36444502, title={Diabetes, metformin use and risk of non-Hodgkin's lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative.}, author={Wang Z and Phillips LS and Rohan TE and Ho GYF and Shadyab AH and Bidulescu A and Rudick CN and Pan K and Chen Z and Luo J}, journal={Int J Cancer}, volume={152}, number={8}, pages={1556-1569}}"}}, {"_id": "36259964", "pmid": 36259964, "title": "Nanocarrier-Assisted Delivery of Metformin Boosts Remodeling of Diabetic Periodontal Tissue via Cellular Exocytosis-Mediated Regulation of Endoplasmic Reticulum Homeostasis.", "journal": "ACS Nano", "authors": ["Zhong W", "Wang X", "Yang L", "Wang Y", "Xiao Q", "Yu S", "Cannon RD", "Bai Y", "Zhang C", "Chen D", "Ji P", "Gao X", "Song J"], "date": "2022-11-22T00:00:00Z", "doi": "10.1021/acsnano.2c08146", "meta_date_publication": "2022 Nov 22", "meta_volume": "16", "meta_issue": "11", "meta_pages": "19096-19113", "score": 50247.492, "text_hl": "Recent studies have shown that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can modulate @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@DM@@@-induced @<m>DISEASE_Lymphoma_Non_Hodgkin</m> @DISEASE_MESH:D008228 @@@ER dysfunction@@@, yet its mechanism remains unclear. ", "citations": {"NLM": "Zhong W, Wang X, Yang L, Wang Y, Xiao Q, Yu S, Cannon RD, Bai Y, Zhang C, Chen D, Ji P, Gao X, Song J. Nanocarrier-Assisted Delivery of Metformin Boosts Remodeling of Diabetic Periodontal Tissue via Cellular Exocytosis-Mediated Regulation of Endoplasmic Reticulum Homeostasis. ACS Nano. 2022 Nov 22;16(11):19096-19113. PMID: 36259964", "BibTeX": "@article{36259964, title={Nanocarrier-Assisted Delivery of Metformin Boosts Remodeling of Diabetic Periodontal Tissue via Cellular Exocytosis-Mediated Regulation of Endoplasmic Reticulum Homeostasis.}, author={Zhong W and Wang X and Yang L and Wang Y and Xiao Q and Yu S and Cannon RD and Bai Y and Zhang C and Chen D and Ji P and Gao X and Song J}, journal={ACS Nano}, volume={16}, number={11}, pages={19096-19113}}"}}, {"_id": "32907360", "pmid": 32907360, "title": "Combination of Scutellaria baicalensis and Metformin Ameliorates Diet-Induced Metabolic Dysregulation in Mice via the Gut-Liver-Brain Axis.", "journal": "Am J Chin Med", "authors": ["Ansari A", "Bose S", "Lim SK", "Wang JH", "Choi YH", "Kim H"], "date": "2020-01-01T00:00:00Z", "doi": "10.1142/S0192415X2050069X", "meta_date_publication": "2020", "meta_volume": "48", "meta_issue": "6", "meta_pages": "1409-1433", "score": 50247.32, "text_hl": "Our findings indicate that SB and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@ co-treatment is an effective therapeutic approach for @<m>DISEASE_Lymphoma_Non_Hodgkin</m> @DISEASE_MESH:D008228 @@@HFFD@@@-induced @DISEASE_Chronobiology_Disorders @DISEASE_MESH:D021081 @@@metabolic dysregulation@@@ which is operated through the gut-liver-brain axis.", "citations": {"NLM": "Ansari A, Bose S, Lim SK, Wang JH, Choi YH, Kim H. Combination of Scutellaria baicalensis and Metformin Ameliorates Diet-Induced Metabolic Dysregulation in Mice via the Gut-Liver-Brain Axis. Am J Chin Med. 2020;48(6):1409-1433. PMID: 32907360", "BibTeX": "@article{32907360, title={Combination of Scutellaria baicalensis and Metformin Ameliorates Diet-Induced Metabolic Dysregulation in Mice via the Gut-Liver-Brain Axis.}, author={Ansari A and Bose S and Lim SK and Wang JH and Choi YH and Kim H}, journal={Am J Chin Med}, volume={48}, number={6}, pages={1409-1433}}"}}, {"_id": "37933643", "pmid": 37933643, "title": "[Metformin mitigates doxorubicin-induced cardiotoxicity via the AMPK pathway].", "journal": "Nan Fang Yi Ke Da Xue Xue Bao", "authors": ["Wei J", "Yang Q", "Lin L", "Zhu C", "Wei J"], "date": "2023-10-20T00:00:00Z", "doi": "10.12122/j.issn.1673-4254.2023.10.05", "meta_date_publication": "2023 Oct 20", "meta_volume": "43", "meta_issue": "10", "meta_pages": "1682-1688", "score": 50244.715, "text_hl": "METHODS: We analyzed the data of 123 patients with @DISEASE_Leukemia_Myeloid @DISEASE_MESH:D007951 @@@myeloid leukemia@@@, @<m>DISEASE_Lymphoma_Non_Hodgkin</m> @DISEASE_MESH:D008228 @@@non-Hodgkin's lymphoma@@@, or @DISEASE_Breast_Neoplasms @DISEASE_MESH:D001943 @@@breast cancer@@@ receiving @CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@doxorubicin@@@ for phased chemotherapy, including 43 patients receiving combined treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (test group) and 80 without @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment (control group). ", "citations": {"NLM": "Wei J, Yang Q, Lin L, Zhu C, Wei J. [Metformin mitigates doxorubicin-induced cardiotoxicity via the AMPK pathway]. Nan Fang Yi Ke Da Xue Xue Bao. 2023 Oct 20;43(10):1682-1688. PMID: 37933643", "BibTeX": "@article{37933643, title={[Metformin mitigates doxorubicin-induced cardiotoxicity via the AMPK pathway].}, author={Wei J and Yang Q and Lin L and Zhu C and Wei J}, journal={Nan Fang Yi Ke Da Xue Xue Bao}, volume={43}, number={10}, pages={1682-1688}}"}}, {"_id": "30091464", "pmid": 30091464, "title": "Use of metformin and survival of patients with high-grade glioma.", "journal": "Int J Cancer", "authors": ["Seliger C", "Luber C", "Gerken M", "Schaertl J", "Proescholdt M", "Riemenschneider MJ", "Meier CR", "Bogdahn U", "Leitzmann MF", "Klinkhammer-Schalke M", "Hau P"], "date": "2019-01-15T00:00:00Z", "doi": "10.1002/ijc.31783", "meta_date_publication": "2019 Jan 15", "meta_volume": "144", "meta_issue": "2", "meta_pages": "273-280", "score": 50070.547, "text_hl": "Use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and survival of @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Lymphoma_Non_Hodgkin</m> @DISEASE_MESH:D008228 @@@high-grade glioma@@@.", "citations": {"NLM": "Seliger C, Luber C, Gerken M, Schaertl J, Proescholdt M, Riemenschneider MJ, Meier CR, Bogdahn U, Leitzmann MF, Klinkhammer-Schalke M, Hau P. Use of metformin and survival of patients with high-grade glioma. Int J Cancer. 2019 Jan 15;144(2):273-280. PMID: 30091464", "BibTeX": "@article{30091464, title={Use of metformin and survival of patients with high-grade glioma.}, author={Seliger C and Luber C and Gerken M and Schaertl J and Proescholdt M and Riemenschneider MJ and Meier CR and Bogdahn U and Leitzmann MF and Klinkhammer-Schalke M and Hau P}, journal={Int J Cancer}, volume={144}, number={2}, pages={273-280}}"}}, {"_id": "31129317", "pmid": 31129317, "title": "Metformin is associated with a lower risk of non-Hodgkin lymphoma in patients with type 2 diabetes.", "journal": "Diabetes Metab", "authors": ["Tseng CH"], "date": "2019-10-01T00:00:00Z", "doi": "10.1016/j.diabet.2019.05.002", "meta_date_publication": "2019 Oct", "meta_volume": "45", "meta_issue": "5", "meta_pages": "458-464", "score": 50059.008, "text_hl": "...BACKGROUND: Whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use might affect the risk of @<m>DISEASE_Lymphoma_Non_Hodgkin</m> @DISEASE_MESH:D008228 @@@non-Hodgkin lymphoma@@@ (@<m>DISEASE_Lymphoma_Non_Hodgkin</m> @DISEASE_MESH:D008228 @@@NHL@@@) remained to be answered. ", "citations": {"NLM": "Tseng CH. Metformin is associated with a lower risk of non-Hodgkin lymphoma in patients with type 2 diabetes. Diabetes Metab. 2019 Oct;45(5):458-464. PMID: 31129317", "BibTeX": "@article{31129317, title={Metformin is associated with a lower risk of non-Hodgkin lymphoma in patients with type 2 diabetes.}, author={Tseng CH}, journal={Diabetes Metab}, volume={45}, number={5}, pages={458-464}}"}}, {"_id": "30833113", "pmid": 30833113, "title": "Chronic Low-grade Inflammatory Phenotype (CLIP) and Senescent Immune Dysregulation.", "journal": "Clin Ther", "authors": ["Chen Y", "Liu S", "Leng SX"], "date": "2019-03-01T00:00:00Z", "doi": "10.1016/j.clinthera.2019.02.001", "meta_date_publication": "2019 Mar", "meta_volume": "41", "meta_issue": "3", "meta_pages": "400-409", "score": 50057.723, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @CHEMICAL_Resveratrol @CHEMICAL_MESH:D000077185 @@@resveratrol@@@ have anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ property and may serve as a promising therapeutic agent for treatment of @<m>DISEASE_Lymphoma_Non_Hodgkin</m> @DISEASE_MESH:D008228 @@@CLIP@@@ and @DISEASE_Frailty @DISEASE_MESH:D000073496 @@@frailty@@@. ", "citations": {"NLM": "Chen Y, Liu S, Leng SX. Chronic Low-grade Inflammatory Phenotype (CLIP) and Senescent Immune Dysregulation. Clin Ther. 2019 Mar;41(3):400-409. PMID: 30833113", "BibTeX": "@article{30833113, title={Chronic Low-grade Inflammatory Phenotype (CLIP) and Senescent Immune Dysregulation.}, author={Chen Y and Liu S and Leng SX}, journal={Clin Ther}, volume={41}, number={3}, pages={400-409}}"}}, {"_id": "30642742", "pmid": 30642742, "title": "Metformin and melatonin improve histopathological outcome of NMU-induced mammary tumors in rats.", "journal": "Pathol Res Pract", "authors": ["Bojková B", "Kajo K", "Kubatka P", "Solár P", "Péč M", "Adamkov M"], "date": "2019-04-01T00:00:00Z", "doi": "10.1016/j.prp.2019.01.007", "meta_date_publication": "2019 Apr", "meta_volume": "215", "meta_issue": "4", "meta_pages": "722-729", "score": 50041.99, "text_hl": "RESULTS: Although neither @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ incidence nor frequency were changed after @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@ and/or @CHEMICAL_Melatonin @CHEMICAL_MESH:D008550 @@@MEL@@@ administration, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@ and @CHEMICAL_Melatonin @CHEMICAL_MESH:D008550 @@@MEL@@@ decreased high-grade/low-grade (@<m>DISEASE_Lymphoma_Non_Hodgkin</m> @DISEASE_MESH:D008228 @@@HG/LG) tumor@@@ ratio. ", "citations": {"NLM": "Bojková B, Kajo K, Kubatka P, Solár P, Péč M, Adamkov M. Metformin and melatonin improve histopathological outcome of NMU-induced mammary tumors in rats. Pathol Res Pract. 2019 Apr;215(4):722-729. PMID: 30642742", "BibTeX": "@article{30642742, title={Metformin and melatonin improve histopathological outcome of NMU-induced mammary tumors in rats.}, author={Bojková B and Kajo K and Kubatka P and Solár P and Péč M and Adamkov M}, journal={Pathol Res Pract}, volume={215}, number={4}, pages={722-729}}"}}, {"_id": "27766700", "pmid": 27766700, "title": "Use of statins offsets insulin-related cancer risk.", "journal": "J Intern Med", "authors": ["Kautzky-Willer A", "Thurner S", "Klimek P"], "date": "2017-02-01T00:00:00Z", "doi": "10.1111/joim.12567", "meta_date_publication": "2017 Feb", "meta_volume": "281", "meta_issue": "2", "meta_pages": "206-216", "score": 50025.48, "text_hl": "The strongest effects were observed for use of @GENE_INS @GENE_3630 @@@insulin@@@ and @DISEASE_Pancreatic_Neoplasms @DISEASE_MESH:D010190 @@@pancreatic cancer@@@ [m: OR 4.5, 95% CI: 3.1-6.6; females (f): OR 4.2, 95% CI: 2.5-7.1], @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylureas@@@ (m: OR 2.8, 95% CI: 1.7-4.6; f: OR 3.0, 95% CI: 2.1-4.2) or @CHEMICAL_Thiazolidinediones @CHEMICAL_MESH:D045162 @@@glitazones@@@ and @DISEASE_Skin_Neoplasms @DISEASE_MESH:D012878 @@@skin cancer@@@ (f: OR 0.54, 95% CI: 0.36-0.80), as well as @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @DISEASE_Prostatic_Neoplasms @DISEASE_MESH:D011471 @@@cancer of the prostate@@@ (m: OR 0.82, 95% CI: 0.75-0.91) and corpus uteri (f: OR 1.7, 95% CI: 1.4-2.0) and @<m>DISEASE_Lymphoma_Non_Hodgkin</m> @DISEASE_MESH:D008228 @@@non-Hodgkin's lymphoma@@@ (f: OR 0.76, 95% CI: 0.64-0.91). ", "citations": {"NLM": "Kautzky-Willer A, Thurner S, Klimek P. Use of statins offsets insulin-related cancer risk. J Intern Med. 2017 Feb;281(2):206-216. PMID: 27766700", "BibTeX": "@article{27766700, title={Use of statins offsets insulin-related cancer risk.}, author={Kautzky-Willer A and Thurner S and Klimek P}, journal={J Intern Med}, volume={281}, number={2}, pages={206-216}}"}}]}